announcements
2008/2007 | 2006 | 2005 | 2004 | 2003
Change of Director's Interest Notice
15 December 2006
Commences Phase I oral trial for CYT997
12 December 2006
Change of Director's Interest Notice
17 November 2006
Appendix 3B
17 November 2006
New Preclinical Candidate Broadens Cancer Pipeline
17 November 2006
Results of Meeting
16 November 2006
Chairman's Address & Presentation to Shareholders
16 November 2006
Change of Director's Interest Notice
13 November 2006
Files for CYT997 Phase I Oral Trial
16 October 2006
Notice of Annual General Meeting
11 October 2006
Change of Director's Interest Notice
5 September 2006
Preliminary Final Report & Full Year Accounts
11 August 2006
Cytopia Completes Sale of Alchemia Stake
7 July 2006
Change of Director's Interest Notice
3 July 2006
Update on cancer drug candidate CYT997
26 June 2006
Ceasing to be a substantial holder for ACL
23 June 2006
PDF Status
22 June 2006
Change of Director's Interest Notice
20 June 2006
Investor Presentation
14 June 2006
Initial Director's Interest Notice
13 June 2006
CEO Appointment
9 June 2006
New Issue Announcement
5 June 2006
Major License and R&D Collaboration
5 June 2006
Trading Halt
2 June 2006
Response to ASX Share Price Query
26 April 2006
New Issue Announcement
20 March 2006
|